Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: J Neuropsychiatry Clin Neurosci. 2020 Oct 28;33(1):3–13. doi: 10.1176/appi.neuropsych.20060152

Figure 4.

Figure 4.

Drugs in clinical trials for Alzheimer’s disease presented by Common Alzheimer’s Disease Research Ontology (CADRO) classification of drug target (blue – Phase 1; orange – Phase 2; green – Phase 3).